Physician

Karl Robert Freydl, DO

According to 2025 Medicare claims, Karl Freydl, DO (NPI: 1720183353) practices interventional pain management (ipm) in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is UNIVERSITY NEUROSURGICAL ASSOCIATES PC (NPI: 1699761379; TIN: 38-2376857) and primary practice location at 48375-1883.

Freydl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 111 traditional Medicare patients, billed 795 HCPCS/CPT codes, and received $47,523 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 428 prescription claims across 118 beneficiaries totaling $9,078 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 9 records totaling $225. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $95,951 and ending at $47,523. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $16,046 and ending at $9,078. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	133	2,433	$95,951
2016	121	5,844	$81,630
2017	130	1,112	$47,740
2018	148	755	$52,774
2019	117	665	$50,877
2020	162	978	$75,959
2021	146	806	$72,370
2022	161	892	$81,465
2023	124	596	$53,774
2024	111	795	$47,523

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	324	$16,046
2016	74	399	$23,932
2017	61	276	$25,055
2018	68	178	$19,549
2019	59	285	$12,424
2020	71	455	$10,478
2021	100	656	$20,806
2022	119	900	$19,842
2023	130	848	$14,788
2024	118	428	$9,078

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	43	60	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	36	48	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	79	163	$67
64484	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level	34	46	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	46	68	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	1,766	$1,335
Gabapentin	Gabapentin	89	3,135	$940
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	824	$564
Duloxetine Hcl	Duloxetine Hcl	28	1,320	$321
Celecoxib	Celecoxib	14	420	$261

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$225	PAINTEQ LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Karl Robert Freydl, DO?

Tedicare shows public-source Medicare data for Karl Robert Freydl, DO (NPI 1720183353), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karl Robert Freydl, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Karl Robert Freydl, DO?

Karl Robert Freydl, DO is linked to UNIVERSITY NEUROSURGICAL ASSOCIATES PC (billing NPI 1699761379) in the available physician profile data.

Does Karl Robert Freydl, DO have Open Payments data?

Karl Robert Freydl, DO has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.